Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Agius

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Annals of the New York Academy of Sciences|November 1, 2003
Introduction. Biochemical basis for disease of the neuromuscular junctionMark A Agius
Therapeutic Advances in Neurological Disorders|March 4, 2014
Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosisRegina Berkovich, Mark A Agius
Neurology|December 25, 2003
Treatment of autoimmune myasthenia gravisDavid P Richman, Mark A Agius
Annals of the New York Academy of Sciences|November 1, 2003
Treatment principles in the management of autoimmune myasthenia gravisDavid P Richman, Mark A Agius
Neurology|December 30, 2004
Current approved options for treating patients with multiple sclerosisSyed A Rizvi, Mark A Agius
Current Protocols in Neuroscience|January 6, 2011
Clinical and neuroimaging assessments for research studies (including drug trials) in multiple sclerosisMichelle L Apperson, Mark A Agius
Journal of the Neurological Sciences|May 3, 2011
Accelerated central nervous system autoimmunity in BAFF-receptor-deficient miceSusan S Kim, David P Richman, Scott S Zamvil, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 6, 2013
Limited utility of current MRI criteria for distinguishing multiple sclerosis from common mimickers: primary and secondary CNS vasculitis, lupus and Sjogren's syndromeSusan S Kim, David P Richman, Wesley O Johnson, et al.
Annals of the New York Academy of Sciences|November 1, 2003
Three forms of immune myastheniaMark A Agius, David P Richman, Robert H Fairclough, et al.
Sleep & Breathing = Schlaf & Atmung|January 25, 2012
Sleepiness, fatigue, and risk of obstructive sleep apnea using the STOP-BANG questionnaire in multiple sclerosis: a pilot studyRobert A Dias, Kimberly A Hardin, Heather Rose, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Annals of the New York Academy of Sciences|November 1, 2003
Introduction. Biochemical basis for disease of the neuromuscular junctionMark A Agius
Therapeutic Advances in Neurological Disorders|March 4, 2014
Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosisRegina Berkovich, Mark A Agius
Neurology|December 25, 2003
Treatment of autoimmune myasthenia gravisDavid P Richman, Mark A Agius
Annals of the New York Academy of Sciences|November 1, 2003
Treatment principles in the management of autoimmune myasthenia gravisDavid P Richman, Mark A Agius
Neurology|December 30, 2004
Current approved options for treating patients with multiple sclerosisSyed A Rizvi, Mark A Agius
Current Protocols in Neuroscience|January 6, 2011
Clinical and neuroimaging assessments for research studies (including drug trials) in multiple sclerosisMichelle L Apperson, Mark A Agius
Journal of the Neurological Sciences|May 3, 2011
Accelerated central nervous system autoimmunity in BAFF-receptor-deficient miceSusan S Kim, David P Richman, Scott S Zamvil, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 6, 2013
Limited utility of current MRI criteria for distinguishing multiple sclerosis from common mimickers: primary and secondary CNS vasculitis, lupus and Sjogren's syndromeSusan S Kim, David P Richman, Wesley O Johnson, et al.
Annals of the New York Academy of Sciences|November 1, 2003
Three forms of immune myastheniaMark A Agius, David P Richman, Robert H Fairclough, et al.
Sleep & Breathing = Schlaf & Atmung|January 25, 2012
Sleepiness, fatigue, and risk of obstructive sleep apnea using the STOP-BANG questionnaire in multiple sclerosis: a pilot studyRobert A Dias, Kimberly A Hardin, Heather Rose, et al.
Pageof 2